Multiple Sclerosis and Related Disorders

Future studies on aHSCT for multiple sclerosis 1:03
Future studies on aHSCT for multiple sclerosis
Riccardo Saccardi • 28 Oct 2022
Proportion of life and incidence of MS in Canadian immigrants 1:40
Proportion of life and incidence of MS in Canadian immigrants
Dalia Rotstein • 27 Oct 2022
Hot topics in NMOSD: immunological & clinical considerations 2:22
Hot topics in NMOSD: immunological & clinical considerations
Kazuo Fujihara • 28 Oct 2022
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS 3:10
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Mar Tintoré • 4 Nov 2022
The ECTRIMS 2022 Event for People with MS 1:53
The ECTRIMS 2022 Event for People with MS
Mar Tintoré • 4 Nov 2022
METEOROID: Phase III trial of satralizumab in patients with MOGAD 2:21
METEOROID: Phase III trial of satralizumab in patients with MOGAD
Kazuo Fujihara • 28 Oct 2022
Clinical implementation of including optical nerve lesions in MS diagnostic criteria 1:30
Clinical implementation of including optical nerve lesions in MS diagnostic criteria
Angela Vidal-Jordana • 26 Oct 2022
Current diagnostic and treatment measures for AQP4-IgG-positive NMOSD 5:25
Current diagnostic and treatment measures for AQP4-IgG-positive NMOSD
Kazuo Fujihara • 28 Oct 2022
Next steps in understanding the genetics behind MS severity 1:15
Next steps in understanding the genetics behind MS severity
Adil Harroud • 27 Oct 2022
Advances in network neurosciences approaches 2:39
Advances in network neurosciences approaches
Lucina Qazi Uddin • 19 Oct 2022
Unmet needs in the diagnostics and treatment of NMOSD 3:00
Unmet needs in the diagnostics and treatment of NMOSD
Kazuo Fujihara • 28 Oct 2022
Genetic contributions to the IgG index in MS 1:01
Genetic contributions to the IgG index in MS
Adil Harroud • 27 Oct 2022
Lipid-dependent processes within CNS demyelination and remyelination 8:02
Lipid-dependent processes within CNS demyelination and remyelination
Gesine Saher • 31 Oct 2022
New agents under investigation to treat AQP4-positive NMOSD 1:32
New agents under investigation to treat AQP4-positive NMOSD
Kazuo Fujihara • 28 Oct 2022
The importance of cholesterol synthesis in acute demyelination 3:38
The importance of cholesterol synthesis in acute demyelination
Gesine Saher • 31 Oct 2022
The association between serum/CSF biomarkers and OCT measures in CIS patients 2:05
The association between serum/CSF biomarkers and OCT measures in CIS patients
Angela Vidal-Jordana • 26 Oct 2022
The content of VJNeurology is intended for healthcare professionals